Home / COR-NTD / NTD ConnectOR / Tanzania

Tanzania

Country operational research priorities:

Lymphatic Filariasis (LF)
1.      Strengthening the Transmission Assessment Survey (TAS) in LF/Onchocerciasis endemic areas
2.      Xenomonitoring of LF during and post TAS
3.      Morbidity Mapping for LF using electronic methods
4.      LF surveillance in Post-TAS districts


Schistosomiasis (SCH)
1.      Determining the targeted population for SCH treatment
2.      Treating SCH high-risk adults in highly endemic areas
3.      Treatment of the focal population for SCH


Soil-Transmitted Helminthiasis (STH) and other Helminths
1.      Community treatment of Albendazole after stopping LF treatment  
2.      Monitoring STH infection in pre-school and school-aged children
3.      Impact of STH and SCH treatment  on other helminths in Pastoralist communities

Onchocesiasis (Oncho)
1.     Strengthening TAS in Oncho-LF endemic areas
2.     Steps towards Stopping MDA in LF/Oncho co endemic districts


Trachoma
1.      Best approach to increase Trachomatous Trichiasis patients' identification and surgery uptake

Cross-cutting
1.      Cost-effectiveness of neglected tropical disease (NTD) interventions in Tanzania
2.      The impact of WASH and Vector Control interventions on NTDs
3.      Best ways of strengthening supply chain for NTD commodities
4.      Improving knowledge on NTDs using through partnerships with mobile phone companies
5.      Estimating the population of school-aged children
6.      What are the effective and appropriate diagnostics and technologies suitable for case detection at different levels?
7.      Understating sociocultural complexities, risk and management of NTDs towards their elimination
8.      Best approach for improving coverage in Nomadic/hard-to-reach communities
9.      Best ways to engage private sector and NGDOs in NTD interventions

Studies

02 March 2021

RQ1 - Reliability assessment: What is the intra- and inter-rater reliability of current qualitative F and novel quantitative hygiene metrics across study contexts?

RQ2 – Validity assessment: What is the validity of each metric of interest (i.e., quantitative hygiene and qualitative F metrics) with regard to recent personal hygiene practices and trachoma outcomes?

RQ3 – Utility assessment: What is the utility of each metric (i.e., qualitative and quantitative)?

RQ4 – Risk factor assessment: Do proxy facial and hand hygiene outcomes, as measured by the novel quantitative hygiene metric, represent risk factors of incident C. trachomatis infection?

 

Districts: Kongwa
Diseases: Trachoma
21 May 2019
  1. To evaluate strategies for the elimination of trachoma by evaluating potential makers that show interruption of transmission of C. trachomatis
  2. To determine the prevalence of ocular chlamydial infection among children aged 1 – 9 years old in Mpwapwa and Kalambo District, Tanzania
  3. To determine the associated risk factors of ocular Chlamydia infection among children aged 1 – 9 years old in Mpwapwa and Kalambo District, Tanzania
  4. To determine the usability of antibody test to detect Chlamydia antigen pgp3 using lateral flow assay
  5. To examine the longevity of the antibody response to trachoma antigens in a high and low-prevalence setting
Districts: Kalambo District
Diseases: Trachoma
04 December 2018

One of important pillar of Trachoma elimination as a public health problem is to manage through epilation and surgery trachomatous trichiasis (TT) to reach in endemic district less than 0.1% of TT prevalence or less than 0.2% prevalence in adults of 15 years and older. However, surveys in 3 districts of Tanzania where numbers of TT surgeries were performed showed an unexpected higher prevalence despite intervention. This mixed methods study will help to address the main question as to why trachoma impact surveys demonstrating unexpectedly high TT prevalence in communities where TT surgical intervention is ongoing and how could this intervention/burden gap be addressed? The aim is to look at the case finding techniques effectiveness in all the communities and factors that affect TT referral and quality surgical services.

Districts: Dodoma District | Lindi District | Mtwara District
Diseases: Trachoma
13 November 2018

Schistosomiasis is among the neglected tropical diseases which are highly endemic in Tanzania, especially along and on the Island of Lake Victoria, in northwestern region. After Nigeria, Tanzania is second country in sub-Saharan Africa for having the highest prevalence of schistosomiasis infection and it is estimated that 52% of approximately 50 million people are living with the disease. Current control strategies in Tanzania focus on mass drug administration (MDA) of Praziquantel (PZQ) mainly in school children. Despite of these efforts, the burden of disease remains high, showing local infection rates of up to 97% among school children. School- based MDA alone is unlikely to have a lasting effect on transmission. Awareness creation and engagement across sectors and of civil society (cooperatives, community councils) structures will help to achieve more sustainable results. The objective of this project is to engage affected communities and civil society structures representing risk population (cooperatives, beach management units) to create awareness through e.g. CHAST (children’s hygiene and sanitation training), participation in control activities and improved health seeking behaviors. Secondarily, the study aims to institutionalize measures for early diagnosis and treatment in health facilities of Nyamagana and Ilemela district, along the Lake Victoria, northwestern Tanzania.

Districts:
Diseases: Schistosomiasis
19 June 2018

The primary aim of this study is a first evaluation (384 samples) of the DjinniChip in ocular clinical samples in a trachoma-endemic region in-country, but initially in the controlled environment of a research laboratory setting. The second aim is to determine the DjinniChips resilience and usability by evaluating its performance with a concentration series of positive control swabs in various environmental conditions (hot, dry, dusty, humid).

Districts:
Diseases: Trachoma
15 May 2018

To investigate the utility of an antibody test as a tool for surveillance during the elimination phase of trachoma programmes

Districts: Mpwapwa District
Diseases: Trachoma
19 March 2018

Main objectives are firstly to identify and understand better the factors behind low and unequal MDA coverage and compliance in trachoma endemic areas in Tanzania and Kenya with nomadic populations, secondly to prioritize factors in terms of amenability to intervention. The researcher will then use the evidence generated to design specific interventions that could improve the reach and impact of campaigns of Zithromax MDA in both countries.  While there are contextual differences between nomadic societies throughout Africa, research among the Masai in Tanzania and Kenya should inform programme services in other settings with nomadic populations. Particular attention will be given to gender-sensitivity; that is, interventions that will improve access and use by women as well as men.

Districts: Longido District & Kiteto District
Diseases: Trachoma
15 February 2018

To assess if introducing point-of-care Circulating Cathodic Antigen rapid test to community health workers will increase access, compliance and coverage to treatment among adult individuals at Kome Island in North-Western Tanzania, an area on the Lake Victoria highly endemic for schistosomiasis

Districts:
Diseases: Schistosomiasis
15 February 2018

To investigate prevalence of ocular chlamydial infection and associated risk factors in children aged 1-9 year in Manyoni district

Districts: Mpwapwa District
Diseases: Trachoma
11 October 2017

The Starworms project aims to strengthen the monitoring and surveillance of drug efficacy and anthelmintic resistance in soil-transmitted helminth (STH) programs. As such, it will support deworming programs in their quest to eliminate STHs as a public health problem by 2020. The specific objectives are (1) to validate diagnostic tools to monitor drug efficacy and the spread of anthelmintic resistance, (2) to create a surveillance system that monitors the global patterns of drug efficacy and spread of anthelmintic resistance in STH programs, and (3) to develop supporting tools to plan, analyze and follow up on surveys on drug efficacy and the spread of anthelmintic resistance.

Districts: Pemba
Diseases: Soil-transmitted helminthiasis
06 September 2017

Our proposal will study the interaction between humans, livestock and wildlife and the role of this transition zone in the transmission of trypanosomes at the edge of the Serengeti National Park in Tanzania. To assess whether focussed control of tsetse is effective, we will develop mathematical models of the transmission of trypanosomes in the transition zone from wildlife-dominated areas on the park boundaries through to livestock-dominated areas outside the parks. The models will enable us to predict the likely extent, duration and cost of interventions required to interrupt the transmission of trypanosomes at boundary areas. 

Districts: Serengeti National Park
Diseases: Human African trypanosomiasis (sleeping sickness)
06 September 2017

Which strategies best strengthen strategic decision making for resilient and responsive health systems at the district level in Ghana, Malawi, Uganda and Tanzania?

Districts:
Diseases: Buruli Ulcer | Chagas disease | Dengue and Chikungunya | Echinococcosis | Foodborne trematodiases | Guinea Worm (Dracunculiasis) | Human African trypanosomiasis (sleeping sickness) | Leishmaniasis | Leprosy (Hansen disease) | Loiasis | Lymphatic filariasis | Mycetoma | Onchocerciasis | Podoconiosis | Rabies | Scabies | Schistosomiasis | Snakebite | Soil-transmitted helminthiasis | Strongyloidiasis | Taeniasis/Cysticercosis | Trachoma | Yaws
05 September 2017

To determine the validity and programmatic feasibility of an integrated transmission assessment survey (F-TAS), to be used to simultaneously assess Onchocerciasis (Oncho) and Lymphatic Filariasis (LF) prevalence in areas co-endemic for the two infections that have completed the recommended treatment for one or both infections.

Districts: Morogoro District
Diseases: Lymphatic filariasis | Onchocerciasis
27 June 2017

To compare Ov16 ELISA and Ov16 rapid diagnostic test results, and better understand the significance of Ov16 serology in hypo-, meso- and hyper-endemic settings post-treatment.

Districts:
Diseases: Onchocerciasis
07 June 2017

To assess filarial exposure in the study population and mosquito infection status prior to and after the start of intensified malaria control interventions.

Districts: Lake Victoria
Diseases: Lymphatic filariasis
20 December 2016

To field-test the Pgp3 lateral flow assay to compare data obtained in the field on the rapid test to that from DBS collected from the same individual tested on the Pgp3 multiplex bead array.

Districts: Kongwa
Diseases: Trachoma
30 September 2016

Is molecular detection of schistosome infection (patent and pre-patent) in snails a useful tool for program managers as prevalence and intensity of infection in people approaches very low levels?

Districts: Zanzibar
Diseases: Schistosomiasis
30 September 2016

How do villages which do not show substantial decreases in the prevalence of schistosomiasis despite repeated, high coverage mass drug administration (persistent hot-spot villages) differ from villages which show substantial decrease in prevalence across various factors (declining prevalence villages)?

Districts:
Diseases: Schistosomiasis
30 September 2016

Economic evaluation of SCORE projects with priority given to elimination studies

 

Districts: Zanzibar
Diseases: Schistosomiasis
24 August 2016

To evaluate strategies to improve the sensitivity of the TAS for detecting evidence of recent lymphatic filariasis transmission in an evaluation unit (EU). The TAS Strengthening Study in Tanzania is designed to assess additional indicators that may be added to the current TAS platform in order to strengthen the resulting stopping or surveillance decisions. A comprehensive analysis will be conducted to understand the correlation between antigen and antibody in adults and children with the mosquito data. A spatial analysis looking at microfoci of infection will also be conducted. Because the EU is also endemic for onchocerciasis, the new Ov16 monoplex RDT was used in the field. The Wb123 and Ov16 antibodies were assessed via ELISA in the NIMR lab in Tanga and the results will soon be compiled.  Xenomonitoring work to assess Culex and Anopheles mosquitoes, as well as black flies, is underway.

Preliminary Findings and Lessons Learned

The ultimate goal of this study is to strengthen the existing TAS platform so that the programs can be more confident with their stopping and surveillance decisions.   In order to strengthen the existing TAS platform we need to better understand which target population(s) and diagnostic indicator(s) are best-suited for identifying areas with persistent transmission that is not expected to cease on its own, knowing that the answer may vary according the primary vector and stage of the program.  In the selected sites a community-based TAS was conducted using the standard sampling of 6-7 year olds while a community TAS (individuals >8 years) was conducted concurrently.  All samples were tested via FTS and DBS (for Wb123 ELISA).  In these same communities a molecular xenomonitoring study will take place and the mosquitoes will be tested for filarial DNA to relate back to the human specimens.  To date human sampling has been completed in all sites and laboratory analysis of the specimens is complete. Mosquito collection has been completed in Haiti and Tanzania and the PCR analysis has been completed in Haiti and is planned for Tanzania (pending the arrival of a new PCR machine).  In American Samoa xenomonitoring has been delayed due to weather conditions and arbovirus outbreaks; work is expected to commence spring 2018.

Districts: Muheza
Diseases: Lymphatic filariasis | Onchocerciasis
31 July 2015

Demonstrate the utility of a new mapping strategy based on school cluster random sampling Using PPES. A secondary objective is to assess the value of laboratory-based antibody assays as confirmatory tests and additional diagnostic tools for measuring LF transmission. 

Districts:
Diseases: Lymphatic filariasis
30 July 2015

Monitor recrudescence of STH after TAS to improve planning of STH programs and more effective use of STH drugs.

Districts: Lushoto
Diseases: Lymphatic filariasis | Soil-transmitted helminthiasis
30 July 2015

Test STH-TAS

Districts: Lushoto
Diseases: Lymphatic filariasis | Soil-transmitted helminthiasis
30 July 2015

Follow-up LF TAS and comparison of ICT and Filariasis Strip Test in a post-MDA surveillance setting.

The multi-country studies on the same topic led to the endorsement by WHO for the FTS as an approved diagnostic tool.

Districts: Tandahimba
Diseases: Lymphatic filariasis
30 July 2015

Analyze the relationships between the prevalence of the clinical sign follicular trachoma (TF) and the prevalence of infection and antibody to determine whether it may be appropriate to consider one or more alternative indicators for deciding whether trachoma programs can stop MDA.

Districts:
Diseases: Trachoma
10 September 2014

SCORE Data Collection on Mobile Devises

Districts:
Diseases: Schistosomiasis
10 September 2014

Cost Studies in SCORE Gaining and Sustaining

Districts:
Diseases: Schistosomiasis
10 September 2014

Human Diagnostics Tool Development (CAA diagnostic tool)

Districts:
Diseases: Schistosomiasis
10 September 2014

Part of gaining control studies

Districts:
Diseases: Schistosomiasis
10 September 2014

Schistosome Population Genetics in Gaining Control Studies in Niger (Sh) and Tanzania (Sm)

Districts:
Diseases: Schistosomiasis
10 September 2014

Gaining Control: >25% Prevalence MDA strategies; and subtle morbidity of Cohort; Population genetics, and snail monitoring

Districts:
Diseases: Schistosomiasis | Soil-transmitted helminthiasis
09 September 2014

(1) Is it possible to eliminate schistosomiasis as a public health problem on Unguja in three years and to interrupt transmission in five years? (2) Is it possible to control schistosomiasis throughout Pemba (prevalence <10%) in three years and to eliminate it as a public health problem in five years? (3) What are the costs, successful strategies, barriers, etc. associated with three different interventions (MDA, vector control, and behavior change)?

Districts:
Diseases: Schistosomiasis